The PHA (Philippine Heart Association) Formulary was soft launched on December 7, 2023 at 3-5 pm at Serenade 2, The Westin Manila. This formulary contains a list and description of locally available drugs considered in national and international clinical practice guidelines to be of importance in the treatment of cardiovascular conditions. However, this does not supplant the Philippine National Formulary which has a more stringent process of vetting drugs based on cost-effectiveness and impact on public health.
Click here to download